Home/ Supplements/ Dim/ Diindolylmethane

Diindolylmethane

product on market Powder BulkSupplements.com Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 100% of ingredients have research evidence
A Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · grounded in 1 source · methodology

Diindolylmethane is researched for its role in modulating estrogen metabolism and supporting hormonal balance. Current clinical evidence for these effects in healthy individuals is limited. The ingredient is generally well-tolerated, though most high-quality human trials remain small in scale.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for Diindolylmethane
Open Full PDF View on NIH DSLD →
Details

Label Data

200 Milligram(s)
Serving Size
5000
Servings
Non-Nutrient/Non-Botanical
Product Type
100%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Market median: 200.0mg (3 products) 11 studies (A:1, B:3)
Claims

Label Claims — Verification

Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Suggested Use: As a dietary supplement, take 200 mg (about 1/10 tsp) one to two times daily, or a directed by a physician.

Warnings & Precautions

Always consult a physician before taking any dietary supplement.

Keep out of reach of children.

Formulation Notes

Free of: Sugar, soy, dairy, yeast, gluten, additives

Diindolylmethane (DIM) Powder

Additional Information

Store in a dry, cool, dark place.

Use an accurate milligram scale. Contents are sold by weight, not volume. Settling may occur. New

Metadata

Product Details

UPC / SKUX0010356ID
DSLD Entry Date2024-04-23
Product TypeNon-Nutrient/Non-Botanical
FormPowder
DSLD ID311511
Data Updated2026-04-11
Research

Research Evidence

5
Research Sources
44
Avg Quality
5
Rct
C A randomized, placebo-controlled trial of diindolylmethane for breast cancer biomarker modulation in patients taking tamoxifen
Rct Breast cancer research and treatment 2017 PubMed DOI
C Phase Ib placebo-controlled, tissue biomarker trial of diindolylmethane (BR-DIMNG) in patients with prostate cancer who are undergoing prostatectomy
Rct European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP) 2016 PubMed DOI
C Effectiveness of 3,3'-Diindolylmethane Supplements on Favoring the Benign Estrogen Metabolism Pathway and Decreasing Body Fat in Premenopausal Women
Rct Nutrition and cancer 2023 PubMed DOI
C The effects of light exposure on the cortisol stress response in human males.
Rct Stress (Amsterdam, Netherlands) PubMed DOI
D Pilot study: effect of 3,3'-diindolylmethane supplements on urinary hormone metabolites in postmenopausal women with a history of early-stage breast cancer
Rct Nutrition and cancer 2004 PubMed
View all evidence for Dim →
Compare

Similar Products

View all Dim products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.